Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients | Zendy

Charles E. Edmiston | Zendy; Candace J. Krepel | Zendy; K. Sue Kehl | Zendy; Gary R. Seabrook | Zendy; Lewis Somberg | Zendy; G. Hossein Almassi | Zendy; Timothy L. Smith | Zendy; Todd A. Loehrl | Zendy; Kellie R. Brown | Zendy; Brian D. Lewis | Zendy; Jonathan B. Towne | Zendy

Open Access

Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients

Author(s) -

Charles E. Edmiston,

Candace J. Krepel,

K. Sue Kehl,

Gary R. Seabrook,

Lewis Somberg,

G. Hossein Almassi,

Timothy L. Smith,

Todd A. Loehrl,

Kellie R. Brown,

Brian D. Lewis,

Jonathan B. Towne

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki348

Subject(s) - bacteroides fragilis , moxifloxacin , microbiology and biotechnology , piperacillin , imipenem , anaerobic bacteria , levofloxacin , ciprofloxacin , clindamycin , trovafloxacin , antimicrobial , quinolone , medicine , antibiotics , biology , antibiotic resistance , bacteria , pseudomonas aeruginosa , genetics

The aim of the study was to analyse the susceptibility of unique and non-duplicate aerobic and anaerobic isolates from surgical patients to a novel des-F(6)-quinolone (garenoxacin) and other selected antimicrobial agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research